Skip to content
HUB Organoids
services
services overview
drug screening
model and assay development
clinical trials in a dish
technology
company
about us
careers
events
latest news
resources
license program
contact
A patient-derived organoid platform to assess the effectiveness of γδTCR cell therapy in solid tumors
X
Have any questions?
